XML 61 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation - Additional Information (Detail)
$ / shares in Units, $ in Millions
9 Months Ended 12 Months Ended
Apr. 10, 2015
shares
Oct. 30, 2013
shares
Sep. 30, 2018
USD ($)
plan
$ / shares
shares
Dec. 31, 2017
shares
Jun. 07, 2018
shares
Dec. 07, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of equity compensation plans | plan     3      
Additional awards granted (in shares)     1,207,984      
Weighted-average exercise price (in dollars per share) | $ / shares     $ 8.74      
Options exercisable, weighted average remaining contractual life     5 years 11 months 5 days      
2005 Aerie Pharmaceutical Stock Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Additional awards granted (in shares)   0        
2013 Omnibus incentive plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Additional awards granted (in shares) 0          
Equity awards (in shares)     10,229,068   4,500,000  
Inducement Award Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Equity awards (in shares)       874,500   418,000
Employee Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation expense | $     $ 78.4      
Weighted-average remaining vesting period     2 years 10 months 21 days      
Restricted stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation expense related to unvested awards | $     $ 20.0      
Weighted-average of remaining vesting period     2 years 10 months 24 days      
Granted (in shares)     264,999      
Vested (in shares)     122,461      
Awards outstanding (in shares)     584,124 447,049    
Restricted stock | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based awards, vesting period     1 year      
Restricted stock | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based awards, vesting period     4 years      
Restricted Stock With Non-Market Performance Conditions            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares)       98,817    
Vested (in shares)     19,764      
Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares)     104,000      
Weighted-average exercise price (in dollars per share) | $ / shares     $ 54.20      
Awards outstanding (in shares)     96,000      
Options exercisable, weighted average remaining contractual life     4 years 5 months 27 days